Novartis Investigative Site

Port de Sagunt, Valencia 46520

0 studies enrolling now · 5 studies all time

What they study most

Alport Syndrome, C3G, Cardiovascular Disease, Diabetic Kidney Disease, Diabetic Nephropathy Type 2, Focal Segmental Glomerulosclerosis, Hypertension, IgA Nephropathy, Immunoglobulin A Nephropathy, Lupus Nephritis, Type 2 Diabetes Mellitus

Studies at this site

• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V — Recruiting now
• Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. — Recruiting now
• Atrasentan in Patients With Proteinuric Glomerular Diseases — Running, not enrolling
• Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early